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Background: The objective of this study was to classify the various types of odontogenic tumours (OTs) using the 
newly updated 2017 world health organization (WHO) histological typing and to analyze the prevalence of these 
tumours among Nigerians as well as to compare the results obtained with reports from world-wide studies.
Material and Methods: The records of four major tertiary hospitals in Nigeria were reviewed over a 12-year (2004-
2015) period. Lesions diagnosed as odontogenic tumours were classified into four groups according to the 2017 
WHO histological typing. Data which consisted of age, sex and site were analyzed using SPSS for Window (ver-
sion 20.0; SPSS Inc., Chicago, IL) and frequency tables were computed.
Results: A total of 582 OTs were recorded and reviewed, benign OTs were 573 (98.5%) cases and malignant OTs 
were 9 (1.5%) cases. Of the benign OTs, the epithelial OTs were the commonest (500; 86%) while the benign mixed 
OTs were the least frequent (21; 3.6%). The mean age was 30±14 years (age range of 3–77years) and the peak age 
was in the third decade (197; 33.8%) of life. There was slight male gender and strong mandibular site predilection. 
Ameloblastoma, was the most frequent OT and it accounted for 75.5% of the OTs, followed by adenomatoid odon-
togenic tumour (8.1%) and odontogenic myxoma (7.2%). Malignant OTs accounted for 1.5% of the OTs.
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Introduction
Odontogenic tumors (OTs) constitute a heterogeneous 
group of diseases arising from the tooth-forming tissues 
or their remnants (1). They possess both diverse clinical 
and histopathologic features and may be derived from 
epithelial, mesenchymal (ectomesenchymal) elements 
or could be mixed.
The first internationally accepted classification system 
for OTs was published in 1971 (2) by the World Health 
Organization (WHO). This was reviewed in1992 (3), 
updated in 2005 (4) and the fourth edition which is the 
most recent WHO classification of OTs was published 
in January 2017 (5). This newly updated classification 
adopts a simpler format of the germ cell layer of origin 
such as epithelial, mesenchymal (ectomesenchymal) and 
mixed odontogenic tumors. And just like the earlier edi-
tions, mainly divided odontogenic tumors into two cat-
egories, based on biologic behavior as malignant and be-
nign. It however updates and restores odontogenic cysts 
that were previously eliminated from the 2005 edition. 
Keratocystic odontogenic tumour (KCOT) and calcify-
ing cystic odontogenic tumour (CCOT) were ‘renamed/
reclassified’ as odontogenic keratocysts and calcifying 
odontogenic cysts respectively. The complex and detailed 
malignant odontogenic tumor classification of the 2005 
edition was also made simpler by this 2017 classification. 
Furthermore, addition of new lesions; primordial odon-
togenic tumor (POT), cementoossifying fibroma (COF) 
and sclerosing odontogenic carcinoma (SOC) were also 
added in the recent classification (5). POT is a rare le-
sion with about ten cases reported in the literature. It is a 
benign mixed odontogenic tumour seen mostly in early 
adolescent with preferential mandibular site. COF of the 
jaws was previously regarded as a composite of ossifying 
fibroma, classified as neoplastic type of fibroosseous le-
sions. It is now re-designated as a benign mesenchymal 
OTs. SOC is a new entity under the classification of ma-
lignant OT with only about 10 cases reported so far in the 
scientific literature. 
Several world-wide reports on OTs were based on the 
1992 WHO histological classifications (6). Reports from 
African (7-17), Asian (6,18-27), European (28-31), North 
American (32-35) and South American (36-39) studies 
show regional differences in the relative frequencies of 
OTs among different population samples. This may be 
attributed to genetic and cultural diversity in the dif-
ferent geographical locations. Previous Nigerian studies 
(8,9,12) that were based on 1992 WHO classification re-
corded ameloblastoma (59-74%), odontogenic myxoma 
(6-16%) and adenomatoid odontogenic tumour (2-13%) 
as the three most prevalent OTs. 
Although many studies (7-9,12,14) have been conducted 
on OTs in Nigerian, all but one (7) of these was based on 
the 1992 WHO classification and all were single-center 
studies. The present study review 582 cases of odonto-
genic tumors histologically diagnosed in four Nigerian 
tertiary hospitals and the OTs were based on the 2017 
WHO histological typing. The prevalence of these tu-
mours among Nigerians was analyzed and the results 
compare with reports from world-wide studies.
Material and Methods
A 12-year (2004-2015) retrospective review of OTs was 
carried out. Information from case files and histopathol-
ogy records of patients with OTs were retrieved from 4 
major tertiary hospitals in Nigeria (the hospitals in Ile-
Ife and Lagos are located in Southern Nigeria, serving 
7 states with the population of about 27,820,934 while 
the hospitals in Kano and Sokoto are located in North-
ern Nigeria and serving 8 states with the population of 
about 36,777,369). Information retrieved consisted of 
demographic data on age, sex, site, radiological presen-
tation and definitive histological diagnosis. OTs were 
further re-classified according to the 2017 WHO his-
tological typing. The benign OTs were categorized into 
three groups; group I (Odontogenic epithelium), group 
II (Odontogenic mesenchyme) and group III (Mixed 
odontogenic tumors) while the malignant OTs were cat-
egorized into Ameloblastic carcinoma, Primary intraos-
seous carcinoma and odontogenic sarcoma. Data was 
analyzed using SPSS for Window (version 20.0; SPSS 
Inc., Chicago, IL) frequency tables were computed.
Results
A total of 582 OTs were recorded over a 12-year period. 
Benign OTs accounted for 98.5% (573 cases) while ma-
lignant OTs (9 cases) accounted for 1.5% in this series. 
Of the benign OTs, the  epithelial OTs (benign histolog-
ic group I) were the most frequently observed (500 cas-
es) and accounted for 86%, while the benign mixed OTs 
(benign histologic group II) were the least frequently 
observed (21 cases) and accounted for 3.6%. Amelo-
blastoma which was the most frequently observed lesion 
accounted for 75.5% of OTs and 76.6% of benign OTs 
followed by adenomatoid odontogenic tumour (8.1% of 
OTs and 8.2% of benign OTs) Table 1. Malignant OTs 
Conclusions: OTs show a geographic variation with tendency for prevalence of the epithelial OTs in Africa. Amelo-
blastoma has a high prevalence among Nigerians and is the most common OTs in Africa. Prevalence of odontoma is 
relatively low in developing African countries like Nigeria when compared to the prevalence in developed countries. 
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Male Female M:F Max Mand Max:Mand
Benign Odontogenic Tumours; 
573 cases (98.5%)
Epithelial origin (500; 86.0%) 
Ameloblastoma
439 (75.5) 250 189 1.3:1   25   414      1:17
Adenomatoid odontogenic tumour     47 (8.1)  28   19 1.5:1   33     14      2.4:1
Calcifying epithelial odontogenic 
tumour
    11 (1.9)     9     2 4.5:1     4 7      1:1.8
Squamous odontogenic tumour  3 (0.5)     2     1    2:1 1 2      1:2
Mixed (Epithelial-mesenchyme) 
origin (21; 3.6%)
Ameloblastic fibroma   9 (1.5)     5     4 1.3:1 4 5      1:1.3
Odontoma     12 (2.1)     4     8    1:2 6 6      1:1
Mesenchymal origin (52; 8.9%)
Odontogenic fibroma     10 (1.7)     4     6    2:3 4 6      1:1.5
Odontogenic myxoma     42 (7.2)   16    26  1:1.6    20    22      1:1.1
Malignant Odontogenic 
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   99
     5
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     2
  483
      1:5
       -
       -
    1:4.9
Table 1. Frequency, gender and site distribution of odontogenic tumours by diagnostic type.
M = Male;  F = Female;  Max = Maxilla;  Mand = Mandible
accounted for 1.5% of OTs (Table 1). Mean age of pa-
tients with OTs was 30.16 (±13.60) years (age range of 
3–77years). OTs were most frequently observed among 
patients in the 3rd decade of life (197 cases; 33.8%) and 
least among elderly patients (6 cases; 1.0%) with ages 
within the 8th decade and above. There was a slight 
male gender and strong mandibular site predilection for 
the OTs (M:F gender  ratio and mandible-maxilla site 
ratio of 1.2:1 and 4.9:1 respectively) Table 2. Unlike the 
other benign OTs, Adenomatoid odontogenic tumour 
showed maxillary site predilection (70.2%). Seventy-
six OTs were recorded in children (aged 15 years and 
below), accounting for 13.1% of the total OTs. All were 
benign, most (54;71.1%) were in the second decade of 
life, ameloblastoma (40;52.6%) constituted more than 
half of the OTs seen in the paediatric population. The 
relative percentages of OTs in selected studies across 
Africa, Asia, South America, North America and Eu-
rope is shown in Table 3.
Discussion
Several studies (7-9,12,14) have been conducted in Nigeria 
on OTs. A large number of these studies were single-center 
studies and therefore may not provide the accurate preva-
lence of OTs in Nigeria. Our series is a multi-centered study 
that compiled data from 4 major tertiary referral hospitals 
in Nigeria. Observation from the present series shows a 
high prevalence of benign OTs and a very low prevalence 
of malignant OTs in Nigerians. This agrees with reports 
from previous studies (9,16,19,30,33) though the observed 
frequency of occurrence of 1.5% for malignant OTs in this 
study is lower than reports of 3.0% (Western China) (6), 
4.1% (Ibadan, Nigeria) (7), 3.4% (Lagos, Nigeria) (8), 1.6% 
(South Africa) (16) and 6.0% (Northern China) (18). 
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Diagnosis
Age Group (years) 
Mean ±SD0-10 11-20 21-30 31-40 41-50 51-60 61-70 70+
AME 10 84 156 97 47 28 12 5 31.44±13.64
AOT 2 18 16 9 2 - - - 23.91±10.67
CEOT - 2 4 5 - - - - 29.20±11.18
SOT - - 1 - - 2 - - 43.00±17.35
AFR - 3 5 - - 1 - - 27.88±12.15
ODONTO 3 4 4 - 1 - - - 18.67±11.34
OF 2 1 2 3 - 1 - 1 28.11±15.27
OM 4 11 5 17 2 2 1 - 28.07±14.02
OS - - 2 - - - - - 14.50±10.61
AME.Ca - - 1 2 2 1 - - 42.17±12.97
PICa - - 1 - - - - - 25.00±0.00
Total 21 123 197 133 54 35 13 6 30.16±13.60 
Table 2. Age distribution of patients with odontogenic tumours.
AME = Ameloblastoma; AOT = Adenomatoid odontogenic tumour; 
CEOT = Calcifying epithelial odontogenic tumour; SOT = Squamous odontogenic tumour; AFR = Ameloblastic fibroma; ODONTO = Odon-
toma; OF = Odontogenic fibroma; OM = Odontogenic myxoma; OS = Odontogenic sarcoma; AME.CA = Ameloblastic carcinoma; PICa = 
Primary intraosseous cell carcinoma








































Cases 582 116 244 266 318 1309 1642 1677 238 362 349 392 218
AME 75.5 80.1 44.6 65.4 73.3 36.5 40.3 48.6 23.7 20.4 23.7 13.5 30.2
AOT 8.1 0.9 10.2 2.3 2.8 2.1 4.1 4.7 5.4 6.6 7.1 3.3 1.8
CEOT 1.9 1.7 1.2 1.1 1.0 0.5 0.6 1.5 2.0 0.6 0.8 1.3 11.0
SOT 0.5 - - 0.4 0.3 - 0.2 0.4 0.4 0.6 - - -
AFR 1.5 1.7 4.5 4.1 3.1 1.0 1.2 0.9 1.7 0.6 1.4 1.5 0.9
ODONTO 2.1 2.6 8.6 - 2.2 6.1 4.7 10.1 22.1 44.7 34.6 51.5 16.1
OF 1.7 1.7 4.1 1.9 1.2 1.6 0.3 0.4 - 5.5 4.5 13.8 1.8
OM/OFM 7.2 7.0 4.9 14.7 11.9 2.6 4.6 3.9 6.3 8.8 17.7 5.1 2.3
Others/ NS - 2.4 1.1 - 0.1 2.0 2.8 0.6 2.3 3.0 1.5 2.0 1.8
Malignant 1.5 - 1.6 4.1 1.3 6.0 3.0 1.3 - 0.3 1.1 0.3 6.0
Table 3. Relative percentage of odontogenic tumours in selected report and the present study.
S/Africa = South Africa; SA = South America; NA = North America; Tanz = Tanzania; NS = Non specified       
AME = Ameloblastoma; AOT = Adenomatoid odontogenic tumour; CEOT = Calcifying epithelial odontogenic tumour; SOT = Squamous 
odontogenic tumour; AFR = Ameloblastic fibroma; ODONTO = Odontoma; 
OF = Odontogenic fibroma; OM = Odontogenic myxoma; OMF = Odontogenic myxofibroma
Ameloblastoma (75.5%) was the most common type 
of OT observed followed by AOT (8.1%) and odonto-
genic myxoma (7.2%). Nigerian studies (8,9,12) based 
on 1992 WHO classification recorded ameloblastoma 
(59-73.3%), odontogenic myxoma (6.5-16%) and AOT 
(2.8-13%) as the three most common OTs whereas a re-
cent Nigerian study (7) based on 2005 WHO classifica-
tion reported ameloblastoma (65.4%) and odontogenic 
myxoma (14.7%) as the two most common OTs.  The re-
port of high frequency of occurrence for ameloblastoma 
and low frequency of occurrence for odontoma are con-
sistent with reports from previous African (8,9,11,16) 
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and Asian (6,21) studies. Reports of high prevalence 
for odontoma from European (30,31) South American 
(33,36,37,39) and North American (32) studies have 
been documented with the highest prevalence in North 
America (51.5%) (32). We report a low frequency of 
odontoma in Nigerians, a pattern of occurrence similar 
to reports from previous African (8,9,11,16) and Asian 
(6,21) studies. This low frequency of odontomas ob-
served may possibly be attributed to underreporting by 
patients and dentists with consequent dearth of records 
of odontoma cases. The positively benign self-limiting 
nature of the growth of odontoma may result in patients 
not seeking treatment or non-documentation of cases by 
general dentists.
The observed slight male gender preponderance for OTs 
though similar to reports by Lawal et al. (7) and Ade-
bayo et al. (9) but contrasts with female gender prepon-
derance reports from Brazil (36), Chile (39) and Mexico 
(33). OTs showed a peak incidence in the third decade 
of life, which was probably related to the marked preva-
lence of ameloblastoma in this age range. The strong 
mandibular site predilection presently observed agrees 
with reports from previous Nigerian studies (7,8,9,12,14) 
which show mandible: maxilla site ratios to range from 
between 2.9:1 and 5.7:1. This however differs from 
equal site predilection reports from South American 
(33,36,39) and European (30) studies which may be as 
a result of the different prevalence of ameloblastoma in 
these areas. Ameloblastoma occurred in all age groups 
and presented with a peak incidence in the third de-
cade. The mean age of 30.16±13.60 years is similar to 
age reports from other studies (6,7,9,10,12,36,39) that 
report mean age ranging between 27.73 to 37.41 years. 
Observed male gender preponderance for ameloblasto-
ma agrees with reports from previous Nigerian studies 
(7,9,12) although a slight predilection for females was 
documented from Turkish (30) and South American 
studies (33,39). The strong mandibular site predilec-
tion for ameloblastoma is consistent with reports from 
studies in the scientific literature (6-9,12,14,29,30). AOT 
was the second most prevalent OTs in our series and it 
showed a site predilection for the maxilla, this is con-
sistent with documented reports from previous studies 
(7,11,33) however, other studies (6,18,30,39) have re-
ported an equal mandibular-maxillary site distribution. 
The male gender predilection observed for AOT agrees 
with reports from previous Nigerian (9) and Chilean (39) 
studies but differ from other reports (6,7,8,14,33,36).   
Odontogenic myxoma (OM) is a relatively rare, lo-
cally invasive benign tumour of mesenchymal origin. 
It is reported to account for between 4.7–17.7% of OTs 
(8,9,11,12,14,30,32,33,36,39) (Table 3). This study re-
corded a prevalence of 7.2% which agrees with previous 
Nigerian (6.5%) (8) and Brazilian (6.3%) (37) studies. 
There were 3 odontogenic fibromas and 15 odontogenic 
myxomas seen in those within the first two decades of 
life in our series which has similarly been documented 
as the most common age group for primordial odon-
togenic tumour. POTs however are composed of vari-
ably cellular loose fibrous tissue with areas resembling 
the dental papilla, entirely surrounded by cuboidal to 
columnar epithelium and resembling the internal epi-
thelium of the enamel organ40. The prevalence of OTs 
in Nigerian children appears to resemble the adult pat-
tern, the epithelial OTs were the commonest (55; 72.4%) 
while the mixed OTs were the least frequent (9; 11.8%) 
and ameloblastoma (52.6%) was the most frequently 
observed lesion, followed by adenomatoid odontogenic 
tumour (17.1%) and odontogenic myxoma (13.1%), this 
is similar to previous Nigerian reports (8,12).
Our series further confirms that malignant OTs are rare 
especially among Nigerians.  Perusal of the scientific 
literature shows that previous African studies (9,16) 
report a similar  low frequency of  occurrence which 
range from between 1.3%-1.6% . This is however slight-
ly higher than reports of 0.3%-1.1% from American 
(32,32,36,39) and European studies (30) but much lower 
than reports from  Asian studies (6,18) that document 
frequencies as high as 3.0-6.0%. 
Conclusions
OTs show a geographic variation with tendency for 
prevalence of the epithelial OTs in Africa. There was 
a slight male gender and strong mandibular site predi-
lection for OTs among Nigerians. Ameloblastoma is the 
most common OTs in Nigerians and odontomas are rare 
among Africans but have been reported to occur more 
in Europe and America. Malignant tumours derived 
from odontogenic tissues rarely occur in Nigerians. 
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